Breast Cancer News

See below for a daily digest of the latest Breast Cancer news.


Breast Cancer News Weekly Digest

See below for a brief overview of last week's articles. Click through to read each piece in its entirety:

Dacogen Shows Promise in Triple-negative Breast Cancer Animal Models, Study Shows

May 25, 2018 11:39 am | Ana Pena

 

breast cancer trialDacogen (decitabine), a medicine used for treating a group of blood cell disorders, may be a potential new treatment for women with triple-negative breast cancer, including those who failed chemotherapy, a study suggests. The study, “DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine,” was published in The Journal of Clinical Investigation. “There is […]
The post Dacogen Shows Promise in Triple-negative Breast Cancer Animal Models, Study Shows appeared first on Breast Cancer News.
Read More
share on TwitterLike Dacogen Shows Promise in Triple-negative Breast Cancer Animal Models, Study Shows on Facebook

Imagion’s Breast Cancer Detection Method Using Magnetic Nanoparticles Moving into Clinical Trials

May 23, 2018 02:13 pm | Marta Figueiredo

 

nanoparticlesImagion Biosystems‘ experimental breast cancer detection method — involving magnetic nanoparticles that stick to breast cancer cells — will be tested in a clinical trial later this year, according to a press release. Although breast cancer detection using mammography has saved the lives of many women, it still fails to detect 10-25 percent of tumors […]
The post Imagion’s Breast Cancer Detection Method Using Magnetic Nanoparticles Moving into Clinical Trials appeared first on Breast Cancer News.
Read More
share on TwitterLike Imagion’s Breast Cancer Detection Method Using Magnetic Nanoparticles Moving into Clinical Trials on Facebook

Herceptin Treatment Time Could be Halved for Breast Cancer, Phase 3 Trial Finds

May 21, 2018 12:20 pm | Marta Figueiredo

 

Herceptin treatmentA shorter Herceptin (trastuzumab) treatment — six months instead of the standard 12 months — is equally effective and carries fewer heart-related adverse effects, a Phase 3 clinical trial found. The results will be presented at the 2018 American Society of Clinical Oncology (ASCO) meeting beginning June 4, in Chicago, in a presentation titled “PERSEPHONE: 6 versus 12 […]
The post Herceptin Treatment Time Could be Halved for Breast Cancer, Phase 3 Trial Findsappeared first on Breast Cancer News.
Read More
share on TwitterLike Herceptin Treatment Time Could be Halved for Breast Cancer, Phase 3 Trial Finds on Facebook

Recent Posts

Program Offering Financial Incentives Encourages Breast Cancer Patients to Exercise More, Study Finds
Breast Cancer ‘Screening Pill’ Could Be on the Horizon, Mice Study Shows
Study Discovers Mutations That Cause Resistance to Lynparza, Similar Therapies
OncoSec, Merck Partner to Test Immunotherapy Combo in Phase 2 Trial for Triple-negative Breast Cancer
Poor Prognosis for Breast Cancers Diagnosed After Negative Screening Mammography

Copyright © 2018 BioNews Services, LLC, All rights reserved. Email Marketing Powered by MailChimp
unsubscribe from this list | update subscription preferences 

Comments